This IGFBP3 enzyme linked immunosorbent assay (ELISA) applies a technique called a quantitative sandwich immunoassay. The microtiter plate has been pre-coated with an Anti-IGFBP3 Antibody. Standards or samples are then added to the microtire plate wells and IGFBP3, if present, will bind to the antibody pre-coated on the wells. In order to quantify the amount of IGFBP3 present in the sample, Anti-IGFBP3 Antibody (Biotin) is added to each well to "sandwich" the IGFBP3 immobilised on the plate. The microtiter plate then undergoes incubation, followed by thorough washing of the wells to remove all unbound components. Next, Avidin-Biotin-Peroxidase Complex is added to each well for a short incubation period, followed by thorough washing of the wells to remove all unbound conjugates. Next, a TMB (3,3',5,5' tetramethyl-benzidine) substrate solution is added to each well. The enzyme (HRP) and substrate are allowed to react over a short incubation period. Only those wells that contain IGFBP3 will exhibit a change in colour. The enzyme-substrate reaction is terminated by the addition of a stop solution and the colour change is measured spectrophotometrically at a wavelength of 450nm ± 2nm.

Platform

Microplate

Detection Type

Colorimetric

Sample Type

Serum, plasma, body fluids, tissue lysates, and cell culture supernatants.

Sensitivity

< 10 pg/ml

Product Range

156-10,000 pg/ml

Reactivity

Human

Recovery

Storage

Store at 2-8°C for 4 months or at -20°C for 8 months.

Synonyms

Acid stable subunit of the 140 K IGF complex, Binding protein 29, Binding protein 53, BP 53, BP53, Growth hormone dependent binding protein , IBP 3, IBP-3, IBP3, IBP3_HUMAN, IGF binding protein 3, IGF-binding protein 3, IGFBP 3, IGFBP-3, Insulin Like Growth Factor Binding Protein 3, Insulin-like growth factor binding protein 3 precursor, Insulin-like growth factor-binding protein 3

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.